Prevalence and predictors of receipt of prenatal information about genetic screening

Prenatal Diagnosis

Volumn 26, Issue 10, 2006, Pages 944-950

  Whitehead, Nedra S ^a,b   Rasmussen, Sonja A ^c   Cox, Shanna ^b   Posner, Samuel F ^b  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Genetic screening; Pregnancy; Prenatal care

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SCREENING; HEALTH INSURANCE; HUMAN; MEDICAL INFORMATION; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

FEMALE; GENETIC SCREENING; HUMANS; INSURANCE, HEALTH; LOGISTIC MODELS; PATIENT EDUCATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 33750574362     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1532     Document Type: Article

References (27)

1. ACOG Committee on Practice Bulletins. 2003. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet Gynecol 102(1): 203-213.
2. American Academy of Pediatrics Committee on Fetus and Newborn. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Guidelines for perinatal care, (4th edn). American College of Obstetricians and Gynecologists: Washington, DC; 1997.
3. Bernhardt BA, Geller G, Doksum T, Larson SM, Roter D, Holtzman NA. 1998. Prenatal genetic testing: content of discussions between obstetric providers and pregnant women. Obstet Gynecol 91(5 Pt 1): 648-655.
4. Chilaka VN, Konje JC, Stewart CR, Narayan H, Taylor DJ. 2001. Knowledge of Down syndrome in pregnant women from different ethnic groups. Prenat Diagn 21(3): 159-164.
5. Dillman DA. 1999. Mail and Internet Surveys: The Tailored Design Method (2nd edn). John Wiley and Sons: New York.
6. Fineman RM, Bell TM. 1999. Assessment of two 'low-tech' genetic health care procedures performed by prenatal care providers in Washington state: implications for future policy development activities. Community Genet 2(2-3): 61-68.
7. Ford C, Moore AJ, Jordan PA, et al. 1998. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population. Br J Obstet Gynaecol 105(8): 855-859.
8. Freda MC, Andersen HF, Damus K, Merkatz IR. 1993. Are there differences in information given to private and public prenatal patients? Am J Obstet Gynecol 169(1): 155-160.
9. Githens PB, Glass CA, Sloan FA, Entman SS. 1993. Maternal recall and medical records: an examination of events during pregnancy, childbirth and early infancy. Birth 20(3): 136-141.
10. Graves JC, Miller KE, Sellers AD. 2002. Maternal serum triple analyte screening in pregnancy. Am Fam Physician 65(5): 915-920.
11. Greenland S. 2004. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol 160(4): 301-305.
12. Halliday J, Lumley J, Watson L. 1995. Comparison of women who do and do not have amniocentesis or chorionic villus sampling. Lancet 345(8951): 704-709.
13. Hamilton SM, Maresh MJ. 1999. Antenatal screening by history taking - a missed opportunity. J Obstet Gynaecol 19(1): 10-14.
14. Khoshnood B, Blondel B, de Vigan C, Breart G. 2004. Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for down syndrome: results of the French National Perinatal Survey of 1998. Am J Public Health 94(3): 484-491.
15. Knott PD, Penketh RJ, Lucas MK. 1986. Uptake of amniocentesis in women aged 38 years or more by the time of the expected date of delivery: a two-year retrospective study. Br J Obstet Gynaecol 93(12): 1246-1250.
16. Kogan MD, Alexander GR, Kotelchuck M, Nagey DA, Jack BW. 1994. Comparing mothers' reports on the content of prenatal care received with recommended national guidelines for care. Public Health Rep 109(5): 637-646.
17. Kuppermann M, Gates E, Washington AE. 1996. Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socioeconomics, or patient knowledge? Obstet Gynecol 87(5 Pt 1): 675-682.
18. Kuppermann M, Nease RF Jr, Gates E, et al. 2004. How do women of diverse backgrounds value prenatal testing outcomes? Prenat Diagn 24(6): 424-429.
19. Michie S, Smith D, Marteau TM. 1999. Prenatal tests: how are women deciding? Prenat Diagn 19(8): 743-748.
20. Petersen R, Connelly A, Martin SL, Kupper LL. 2001. Preventive counseling during prenatal care: Pregnancy Risk Assessment Monitoring System (PRAMS). Am J Prev Med 20(4): 245-250.
21. Richards SH, Coast J, Peters TJ. 2003. Patient-reported use of health service resources compared with information from health providers. Health Soc Care Community 11(6): 510-518.
22. Rowe RE, Garcia J, Davidson LL. 2004. Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review. Public Health 118(3): 177-189.
23. Saridogan E, Djahanbakhch O, Naftalin AA. 1996. Screening for Down's syndrome: experience in an inner city health district. Br J Obstet Gynaecol 103(12): 1205-1211.
24. Sciamanna CN, Goldstein MG, Marcus BH, Lawrence K, Pinto BM. 2004. Accuracy of recall of exercise counseling among primary care patients. Prev Med 39(6): 1063-1067.
25. Sokal DC, Byrd JR, Chen AT, Goldberg MF, Oakley GP Jr. 1980. Prenatal chromosomal diagnosis. Racial and geographic variation for older women in Georgia. JAMA 244(12): 1355-1357.
26. Tilley BC, Barnes AB, Bergstralh E, et al. 1985. A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol 121(2): 269-281.
27. Wapner R, Thom E, Simpson JL, et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. 2003. First-trimester screening for trisomies 21 and 18. N Engl J Med 349(15): 1405-1413.